Literature DB >> 26408106

Increased coronary lipid accumulation in heart transplant recipients with prior high-grade cellular rejection: novel insights from near-infrared spectroscopy.

Bo Zheng1,2,3, Akiko Maehara4,5, Gary S Mintz2, Tamim M Nazif1,2, Yarden Waksman1, Fuyu Qiu1,2, Luz Jaquez1, LeRoy E Rabbani1, Mark A Apfelbaum1, Ziad A Ali1,2, Kate Dalton1, Lei Song1,2,6, Ke Xu2, Charles C Marboe1, Donna M Mancini1, Giora Weisz1,2,7.   

Abstract

Cardiac allograft vasculopathy is a major cause of morbidity and mortality among patients after heart transplantation. We sought to assess the amount of lipid accumulation in the coronary arteries of transplant patients according to rejection grade. Overall, 39 consecutive heart transplant recipients undergoing annual routine surveillance coronary angiography underwent near-infrared spectroscopy and intravascular ultrasound imaging of 1 coronary artery. Rejection history was graded according to the International Society of Heart and Lung Transplantation (ISHLT) classification as none/mild/moderate-grade rejection (ISHLT 0, 1A/1B, or 2) compared to high-grade rejection (≥3A). Patients with prior history of high-grade rejection had larger plaque burden in the distal coronary segments [45.7 % (25.5-63.7) vs 25.1 % (19.9-37.8), p = 0.02] and a higher maximum lipid core burden index in any 4-mm long segment (maxLCBI(4mm)) [243 (91-400) vs 41 (1-170), p = 0.016] as compared with patients with prior history of none/mild/moderate-grade rejection. By multivariable linear regression analysis, prior history of high-grade rejection was an independent predictor for maxLCBI(4mm). A maxLCBI(4mm) >200 distinguished prior history of high-grade from none/mild/moderate rejection with a sensitivity of 61.5 % and specificity of 84.6 %. The current study demonstrates that the coronary arteries of post heart-transplant patients with a prior history of high-grade cellular rejection have increasing amounts of lipid-rich plaque. MaxLCBI(4mm) >200 might differentiate patients with previous high-grade cellular rejection from heart transplant recipients with none/mild/moderate-grade rejection.

Entities:  

Keywords:  Imaging; NIRS; Transplantation; Vasculature

Mesh:

Substances:

Year:  2015        PMID: 26408106     DOI: 10.1007/s10554-015-0777-9

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  32 in total

Review 1.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Authors:  G S Mintz; S E Nissen; W D Anderson; S R Bailey; R Erbel; P J Fitzgerald; F J Pinto; K Rosenfield; R J Siegel; E M Tuzcu; P G Yock
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

2.  First-in-man clinical use of combined near-infrared spectroscopy and intravascular ultrasound: a potential key to predict distal embolization and no-reflow?

Authors:  Carl J Schultz; Patrick W Serruys; Martin van der Ent; Jurgen Ligthart; Frits Mastik; Scott Garg; James E Muller; Mark A Wilder; Anton F W van de Steen; Evelyn Regar
Journal:  J Am Coll Cardiol       Date:  2010-07-20       Impact factor: 24.094

3.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

4.  Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments.

Authors:  Jun Pu; Gary S Mintz; Sinan Biro; Jin-Bae Lee; Stephen T Sum; Sean P Madden; Allen P Burke; Pei Zhang; Ben He; James A Goldstein; Gregg W Stone; James E Muller; Renu Virmani; Akiko Maehara
Journal:  J Am Coll Cardiol       Date:  2014-03-26       Impact factor: 24.094

5.  Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Authors:  Susan Stewart; Gayle L Winters; Michael C Fishbein; Henry D Tazelaar; Jon Kobashigawa; Jacki Abrams; Claus B Andersen; Annalisa Angelini; Gerald J Berry; Margaret M Burke; Anthony J Demetris; Elizabeth Hammond; Silviu Itescu; Charles C Marboe; Bruce McManus; Elaine F Reed; Nancy L Reinsmoen; E Rene Rodriguez; Alan G Rose; Marlene Rose; Nicole Suciu-Focia; Adriana Zeevi; Margaret E Billingham
Journal:  J Heart Lung Transplant       Date:  2005-06-20       Impact factor: 10.247

6.  Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients.

Authors:  Andreas König; Eckehard Kilian; Hae-Young Sohn; Johannes Rieber; Thomas Michael Schiele; Uwe Siebert; Raffaella M Gothe; Bruno Reichart; Volker Klauss
Journal:  J Heart Lung Transplant       Date:  2008-03       Impact factor: 10.247

Review 7.  Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.

Authors:  G Vassalli; A Gallino; M Weis; W von Scheidt; L Kappenberger; L K von Segesser; J-J Goy
Journal:  Eur Heart J       Date:  2003-07       Impact factor: 29.983

8.  Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.

Authors:  Eugenia Raichlin; Jang-Ho Bae; Sudhir S Kushwaha; Ryan J Lennon; Abhiram Prasad; Charanjit S Rihal; Amir Lerman
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

9.  Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system.

Authors:  Craig M Gardner; Huwei Tan; Edward L Hull; Jennifer B Lisauskas; Stephen T Sum; Thomas M Meese; Chunsheng Jiang; Sean P Madden; Jay D Caplan; Allen P Burke; Renu Virmani; James Goldstein; James E Muller
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

10.  Does acute cellular rejection correlate with cardiac allograft vasculopathy?

Authors:  Mohamad H Yamani; Mohammed Yousufuddin; Randall C Starling; Murat Tuzcu; Norman B Ratliff; Daniel J Cook; Ashraf Abdo; Tim Crowe; Robert Hobbs; Gustavo Rincon; Corine Bott-Silverman; Patrick M McCarthy; James B Young
Journal:  J Heart Lung Transplant       Date:  2004-03       Impact factor: 10.247

View more
  2 in total

1.  Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.

Authors:  Kozo Okada; William F Fearon; Helen Luikart; Hideki Kitahara; Kyuhachi Otagiri; Shigemitsu Tanaka; Takumi Kimura; Paul G Yock; Peter J Fitzgerald; Alan C Yeung; Hannah A Valantine; Kiran K Khush; Yasuhiro Honda
Journal:  J Am Coll Cardiol       Date:  2016-07-26       Impact factor: 24.094

2.  The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis.

Authors:  Dominika Klimczak-Tomaniak; Stefan Roest; Jasper J Brugts; Kadir Caliskan; Isabella Kardys; Felix Zijlstra; Alina A Constantinescu; Jolanda J C Voermans; Jeroen J A van Kampen; Olivier C Manintveld
Journal:  Transplantation       Date:  2020-07       Impact factor: 5.385

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.